Biosimilar ‘Patent Dance’: Federal Circuit Rules 180-Day Notice is Mandatory
July 5, 2016
Zachary Brennan
Regulatory Focus
Axinn counsel Stacie Ropka was quoted in the Regulatory Focus article, "Biosimilar ‘Patent Dance’: Federal Circuit Rules 180-Day Notice is Mandatory."